Why qualitative research matters in MedTech (and why it’s often undervalued)
By Hazel Haskayne, Director
MedTech is one of the most evidence-driven industries in the world. Clinical data, real-world evidence and outcomes metrics are everywhere, most MedTech companies are not short on information. From clinical trial results, market sizing and segmentation models to usage metrics and dashboards, as well as essential post-market surveillance data.
And yet some of the most critical decisions MedTech companies make still fail for one simple reason: they don’t understand the human behind the data.
Behavioural economics has long highlighted the importance of context. Data without context will only get you so far. MedTech companies need to understand why clinicians behave the way they do, how decisions actually get made inside hospitals, what ‘risk’ really means to different stakeholders and where friction exists within workflows, perceptions and emotions.
MedTech decisions are human before they are rational
On paper, many decisions in MedTech appear purely logical: safety, efficacy, cost and outcomes. In reality, decisions are shaped by a far more complex set of influences:
Habit and muscle memory in clinical practice
Fear of error and reputational risk
Time pressure and cognitive overload
Departmental politics and institutional dynamics
Trust (or lack of trust) in suppliers
These dynamics rarely appear in spreadsheets!
What qualitative research reveals
Qualitative research surfaces many unspoken topics, behaviours and needs: workarounds clinicians ‘learn’ to rely on, frustrations that are no longer verbalised, trade-offs made when under pressure and, of course, the emotional cost of adopting something new. Without this understanding, even clinically superior technology and devices struggle to scale.
Where qualitative research creates real value
Qualitative research creates value across several critical areas of MedTech strategy:
Revealing unmet needs that can’t easily be articulated
Clinicians are healthcare experts, not specialists in imagining alternative futures. Qualitative research helps reveal needs that are often hidden within routine practice, problems that have become normalised over years of experience, and opportunities that extend beyond incremental product development.
Critical for: Innovation, platform design, digital tools
De-risking innovation before it’s too late
Many MedTech failures are not technical — they are behavioural. Qualitative insight can reveal workflow incompatibilities, training burdens, misaligned value propositions, and adoption barriers long before large investments are committed.
Critical for: Saving years of development, avoiding significant sunk costs
Understanding how trust is built (and lost)
Trust is the currency of MedTech, yet it is rarely examined directly. Qualitative research helps explore the signals that create credibility, how brand, evidence, and experience interact, and why some companies are forgiven mistakes while others are not.
Critical for: Brand strategy, portfolio architecture, partnerships
Making sense of complex buying ecosystems
MedTech purchasing decisions rarely have a single owner. Qualitative exploration can map influencers, decision signatories, and the moments in which decisions stall due to conflicting priorities across stakeholders.
Critical for: Building targeted, action-focused commercial strategies
Turning evidence into meaning
Clinical data does not speak for itself. Qualitative research helps organisations understand how evidence is interpreted, what level of proof is sufficient, and how data fits into real decision-making moments.
Critical for: Message development, education and information programmes, sharper, more honest engagement strategies
Why qualitative research is uniquely suited to MedTech
MedTech sits at the intersection of high expertise, high regulation and high emotional stakes. In that environment, surface-level questioning is rarely effective.
Well-designed qualitative research creates space for reflection rather than recall, for stories rather than justification, and importantly exploration rather than defence. It respects the expertise of clinicians and decision-makers, and in return uncovers insights that surveys alone rarely reach.
A strategic input, not a ‘soft’ one
As MedTech becomes more integrated, digital and system-based, understanding human behaviour will become more (not less) important.
Qualitative research sharpens strategy, de-risks innovation, aligns organisations and ultimately helps better technology reach the patients it was designed for. The MedTech companies that invest in it properly don’t just learn more, they can make better decisions, faster.